iotrolan has been researched along with Inflammation in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ginai, AZ | 1 |
| Bubberman, A | 1 |
| Zondervan, PE | 1 |
| Van Leeuwen, W | 1 |
| Morcos, SK | 1 |
1 other study available for iotrolan and Inflammation
| Article | Year |
|---|---|
The histological response of the lungs of rats to potentially suitable water soluble bronchographic contrast agents iotrolan (a non-ionic dimer) and iopamidol (a non-ionic monomer).
Topics: Animals; Bronchi; Contrast Media; Inflammation; Iopamidol; Lung; Male; Radiography; Rats; Rats, Wist | 1993 |